Bicycle Price to Book Value from 2010 to 2024
| BCYC Stock | USD 21.82 0.48 2.15% |
Check Bicycle Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bicycle main balance sheet or income statement drivers, such as Tax Provision of 1.5 M, Interest Income of 14.7 M or Discontinued Operations of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 40.62, Dividend Yield of 0.0 or PTB Ratio of 0.97. Bicycle financial statements analysis is a perfect complement when working with Bicycle Therapeutics Valuation or Volatility modules.
Bicycle | Price to Book Value |
About Bicycle Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Bicycle Therapeutics income statement, its balance sheet, and the statement of cash flows. Bicycle Therapeutics investors use historical funamental indicators, such as Bicycle Therapeutics's Price to Book Value, to determine how well the company is positioned to perform in the future. Although Bicycle Therapeutics investors may use each financial statement separately, they are all related. The changes in Bicycle Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bicycle Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bicycle Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bicycle Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom. Bicycle Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 119 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bicycle Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bicycle Therapeutics' short interest history, or implied volatility extrapolated from Bicycle Therapeutics options trading.
Pair Trading with Bicycle Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bicycle Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bicycle Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Bicycle Stock
| 0.83 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
| 0.72 | BMY | Bristol Myers Squibb Financial Report 25th of April 2024 | PairCorr |
Moving against Bicycle Stock
| 0.83 | AMGN | Amgen Inc Financial Report 25th of April 2024 | PairCorr |
| 0.8 | BIIB | Biogen Inc Financial Report 23rd of April 2024 | PairCorr |
| 0.66 | ABVC | ABVC Biopharma | PairCorr |
| 0.5 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
The ability to find closely correlated positions to Bicycle Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bicycle Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bicycle Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bicycle Therapeutics to buy it.
The correlation of Bicycle Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bicycle Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bicycle Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bicycle Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Bicycle Therapeutics Correlation against competitors. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Bicycle Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Revenue Per Share 0.758 | Quarterly Revenue Growth 0.674 | Return On Assets (0.24) | Return On Equity (0.56) |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.